Ambu Sdn Bhd -previously known as Medicotest Sdn Bhd - commenced its operations in Asia on 1stApril 1995. Medicotest bought over a small company in Singapore, with production facilities in Penang. In early 1996, its Singapore operations were closed and consolidated with its Penang plant. With only about 20 staff, the company's production was limited to some very specific OEM products. The company transferred part of its Danish operations to its Penang plant and subsequently increased its production capacity-thereby cementing the company's presence in Malaysia. Ambu's current investment in Malaysia is RM16.5 million.
The company currently manufactures medical devices such as disposable medical electrodes, needle electrodes, defibrillation electrodes and new concept for neo natal electrodes at is plant in Penang. The company also develops, produces and markets diagnostic and life-supporting devices for hospitals and rescue services. The products manufactured at its Penang plant are the cardiology and neurology segments of the medical devices market.
In mid-2004, Ambu embarked on an expansion and build a new factory in the Bayan Lepas Free Industrial Zone. The ground breaking ceremony took place on 27th February 2005, and only 8 months later on 27th October, Ambu was handed over the keys to the completed new factory-an achievement and a testimony to Malaysia's ability to meet the requirements of investors.
After less than a year, Ambu sees the need for expanding its production in the future. The company is optimistic of manufacturing new products, while increasing the production capacity of existing ones. The company expects to expand its plant on its remainder plot of land within a few years. Despite being a small to medium sized company, Ambu has grown considerably since its inception 11 years ago. The availability of skilled Malaysian workforce has enabled the company to grow and currently it employs 220 people. The company is confident of future expansion as a result of the conducive investment environment prevailing and supporting services available for companies in the medical devices industry, in the country.
"The choice to locate in Malaysia was by "coincidence", but having been here for quite some time, it became evident that this "coincidence" has developed into a success story. There has never been any doubt in the minds of the local management that Malaysia is a good place to invest. The political stability and good infrastructure has played a significant role in convincing the Ambu Board, of investing further in the country. Malaysia is a safe place for long term investments for a business like ours", says Managing Director, Jorgen Andreasen.
Ambu's major export markets are Europe, US and Japan. The company's vision is to build strong and lasting relations with its customers and have a deeper understanding of their needs, which often exceeds their expectations.The Malaysian medical devices industry, which is expected to register anaverage growth rate of 8.6 % per cent per annum, with exports reaching RM18.4 billion under the Third Industrial Master Plan (2006-2020), should augur well for Ambu's operations in Malaysia in the years ahead.